Literature DB >> 21531627

Harnessing immune responses against Plasmodium for rational vaccine design.

Bruno Douradinha1, Denise L Doolan.   

Abstract

In recent years, groundbreaking advances have been made in understanding the biology of and immune mechanisms against the Plasmodium spp. parasite, the causative agent of malaria. Novel features of the Plasmodium life cycle have been unravelled and immune mechanisms, which take place during both infection and immunization, have been dissected. We have undoubtedly enhanced our knowledge, but the question now is how to use this information to manipulate immune responses against Plasmodium and to develop an efficacious malaria vaccine. In this review, we discuss the latest developments in the field and speculate on how immune responses against Plasmodium could be harnessed for rational vaccine design and application.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531627     DOI: 10.1016/j.pt.2011.01.002

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  14 in total

1.  Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver.

Authors:  Bruno Douradinha; Melissa van Dijk; Geert-Jan van Gemert; Shahid M Khan; Chris J Janse; Andy P Waters; Robert W Sauerwein; Adrian Jf Luty; Bruno Silva-Santos; Maria M Mota; Sabrina Epiphanio
Journal:  J Immune Based Ther Vaccines       Date:  2011-10-17

2.  Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model.

Authors:  Sophie Schussek; Angela Trieu; Simon H Apte; John Sidney; Alessandro Sette; Denise L Doolan
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

Review 3.  Ethnomedicines and anti-parasitic activities of Pakistani medicinal plants against Plasmodia and Leishmania parasites.

Authors:  Akash Tariq; Muhammad Adnan; Rahila Amber; Kaiwen Pan; Sakina Mussarat; Zabta Khan Shinwari
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-09-20       Impact factor: 3.944

4.  CD4+ T cell response correlates with naturally acquired antibodies against Plasmodium vivax tryptophan-rich antigens.

Authors:  Mohammad Zeeshan; Kriti Tyagi; Yagya D Sharma
Journal:  Infect Immun       Date:  2015-03-02       Impact factor: 3.441

Review 5.  T cell exhaustion in protozoan disease.

Authors:  Jason P Gigley; Rajarshi Bhadra; Magali M Moretto; Imtiaz A Khan
Journal:  Trends Parasitol       Date:  2012-07-24

6.  Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.

Authors:  Lais H Teixeira; Cibele A Tararam; Marcio O Lasaro; Ariane G A Camacho; Jonatan Ersching; Monica T Leal; Sócrates Herrera; Oscar Bruna-Romero; Irene S Soares; Ruth S Nussenzweig; Hildegund C J Ertl; Victor Nussenzweig; Mauricio M Rodrigues
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

7.  Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.

Authors:  Stephen A Kaba; Margaret E McCoy; Tais A P F Doll; Clara Brando; Qin Guo; Debleena Dasgupta; Yongkun Yang; Christian Mittelholzer; Roberta Spaccapelo; Andrea Crisanti; Peter Burkhard; David E Lanar
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

Review 8.  Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer.

Authors:  Riccardo Gottardi; Bruno Douradinha
Journal:  J Nanobiotechnology       Date:  2013-09-11       Impact factor: 10.435

9.  Recombinant DBL2β-PfEMP1 of the Indonesian Plasmodium falciparum induces immune responses in Wistar rats.

Authors:  Sheilla Rachmania; Erma Sulistyaningsih; Anak Agung I Ratna Dewi
Journal:  J Taibah Univ Med Sci       Date:  2021-01-15

Review 10.  Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines.

Authors:  Susanne H Sheehy; Alexander D Douglas; Simon J Draper
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.